Knowthestock.com
ELAN - Elanco Animal Health, Inc.

Sell

Weak GrowthEarnings/Profit is Negative

21%

based on last 5 year data.
Income Statement is WEAK
Revenue Growth is -5.28%
Operating Income is Negative
Net Income is Negative
Earnings Per Share (EPS) is Negative
Net Margin is -8.45%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 1.75
Debt Ratio is 0.52
Current Debt to Net Income Ratio not available
Total Debt to Total Assets Ratio is 0.36
Cash Flow is WEAK
Cash from Operations Growth is -24.91%
Capital Expenditure not available
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Elanco Animal Health, Inc. (ELAN) - http://www.elanco.com
Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.
Exchange - New York Stock Exchange
Industry - Agricultural Commodities/Milling
Sector - Process Industries
CEO - Jeffrey N. Simmons
Employees - 5,760
    Close


Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.